NFKB1 and colitis: Overall, these results suggest that Bu can regulate αMCA, HDCA, and isoLCA concentrations in the colon, inhibiting TH17 differentiation in colonic epithelial cells and the expression of downstream NF-κB and MAPK signaling pathways, thus alleviating DSS-induced colitis.